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Although persistent elevations in circulating glucose
concentrations promote compensatory increases in
pancreatic islet mass, unremitting insulin resistance
causes deterioration in beta cell function that leads
to the progression to diabetes. Here, we show that
mice with a knockout of the CREB coactivator
CRTC2 in beta cells have impaired oral glucose
tolerance due to decreases in circulating insulin con-
centrations. CRTC2 was found to promote beta cell
function in part by stimulating the expression of the
transcription factor MafA. Chronic hyperglycemia
disrupted cAMP signaling in pancreatic islets by acti-
vating the hypoxia inducible factor (HIF1)-dependent
induction of the protein kinase A inhibitor beta
(PKIB), a potent inhibitor of PKA catalytic activity.
Indeed, disruption of the PKIB gene improved islet
function in the setting of obesity. These results
demonstrate how crosstalk between nutrient and
hormonal pathways contributes to loss of pancreatic
islet function.INTRODUCTION
The second messenger cAMP has been shown to mediate ef-
fects of incretin hormones, in part through induction of the Ser/
Thr protein kinase PKA. Blocking cAMP signaling in beta cells
through targeted disruption of the Gsa subunit of the heterotri-
meric G protein leads to severe glucose intolerance and beta
cell apoptosis (Xie et al., 2007). Conversely, mutations that in-
crease PKA activity, either via disruption of the R1a regulatory
subunit (Song et al., 2011) or via a gain-of-function mutation in
the PKA catalytic subunit (Kaihara et al., 2013), enhances insulin
secretion.
cAMP promotes cellular gene expression via the PKA-medi-
ated phosphorylation of the CREB family of activators and via
the de-phosphorylation of the cAMP-regulated transcriptional
coactivators (CRTCs). Following its activation, CREB has been
found to promote islet function in part by upregulating the insulinCell Rreceptor substrate 2 (IRS2) in beta cells (Jhala et al., 2003; Park
et al., 2006). Although deletion of the single family member
CREB1 alone has no effect on beta cell function under normal
chow conditions (Shin et al., 2014), expression of a dominant-
negative CREB polypeptide A-CREB, which blocks all three
family members (CREB1, ATF1, and CREM), leads to severe
hyperglycemia due in part to reductions in glucose-stimulated
insulin secretion (Jhala et al., 2003).
IRS2-dependent increases in insulin signaling are thought
to promote islet growth through the activation of mTORC1 com-
plexes and subsequent induction of the hypoxia-inducible factor
HIF1 (Van de Velde et al., 2011; Gunton et al., 2005). Although the
mTORC1-HIF pathway appears to be critical for adaptive expan-
sion of pancreatic islet mass, beta cell function deteriorates in
the setting of chronic insulin resistance (Zhao et al., 1998). Based
on the ability for GLP1 agonists to improve beta cell function
in this setting, we examined the potential role of CREB and
CRTC2 in mediating these effects.RESULTS
Exposure of INS1 insulinoma cells to the cAMP agonist forskolin
(FSK) promoted the phosphorylation of CREB at Ser133 and
the de-phosphorylation of CRTC2 within 30 min (Figure 1A).
By contrast, exposure to depolarizing concentrations of KCl
(40 mM) stimulated CREB phosphorylation to a lesser extent.
Under basal conditions, CRTC2 was sequestered in the cyto-
plasm of beta cells from cultured islets; exposure to FSK trig-
gered CRTC2 nuclear translocation (Figure 1B).
GLP1 and other incretin hormones are released from intestinal
cells only following nutrient ingestion (Holst et al., 2011), so we
analyzed effects of oral glucose tolerance testing (OGTT) in
mice with a beta-cell-specific knockout of CRTC2 (MIP-T2KO;
Figure S1A). Although they were almost comparable to control
littermates by intraperitoneal glucose tolerance test (IPGTT),
MIP-T2KO mice showed impaired glucose tolerance by OGTT
test (Figures 1C and S1B). Indeed, we observed similar differ-
ences between control and MIP-T2KO mice following intra-
peritoneal (i.p.) injection of exendin-4 in addition to glucose
(Figure S1C). Arguing against an increase in insulin resistance,
circulating glucose concentrations decreased identically in
MIP-T2KO mice and control littermates following insulineports 10, 1149–1157, February 24, 2015 ª2015 The Authors 1149
Figure 1. Impaired Glucose Tolerance in
Mice with a Beta-Cell-Specific Knockout
of CRTC2
(A and B) De-phosphorylation and nuclear trans-
location of CRTC2 in INS1 (A) and mouse
pancreatic islets (B) following exposure to cAMP
agonist forskolin (FSK) or KCl.
(C) Oral glucose tolerance testing (OGTT) of mice
with a knockout of CRTC2 in beta cells (MIP-
T2KO) relative to control littermates (*p < 0.05;
**p < 0.01; ***p < 0.001; n = 10).
(D) Insulin tolerance testing of control and MIP-
T2KO mice.
(E) Circulating insulin concentrations in MIP-T2KO
and control littermates 10 min following adminis-
tration of glucose (**p < 0.01; n = 10).
(F) Effect of glucose alone (20 mM) or plus exendin
(10 nM) on insulin secretion from primary cultured
islets of MIP-T2KO and control littermates (**p <
0.01; n = 6).
(G) Insulin content in pancreatic islets from CRTC2
mutant or control littermates (*p < 0.05; n = 6).
(H) Effect of CRTC2 or dominan- negative A-CREB
overexpression on insulin secretion from INS1
cells (*p < 0.05; ***p < 0.001; n = 5). Data are shown
as mean ± SEM.administration (Figure 1D). Rather,MIP-T2KOmice secreted less
insulin in response to oral glucose gavage, suggesting that beta
cell function is disrupted in these animals (Figure 1E).
We evaluated effects of CRTC2 on insulin secretion from
cultured islets in response to cAMP. Following 10 min exposure
to exendin-4 plus high glucose (20 mM), insulin release from
MIP-T2KO islets was reduced 30% (Figure 1F) relative to control
islets. Exposure to glucose alone stimulated insulin secretion
comparably in cultured islets from wild-type and MIP-T2KO
mice (Figure 1F). Insulin (Ins1 and Ins2) gene expression and pro-
tein content were also modestly decreased in MIP-T2KO islets
(Figures 1G and S1D). Conversely, overexpression of CRTC2 in
INS1 insulinoma cells enhanced insulin secretion in response to
GLU/FSK. These effects were blocked by expression of a domi-
nant-negative CREB polypeptide called A-CREB (Figure 1H).1150 Cell Reports 10, 1149–1157, February 24, 2015 ª2015 The AuthorsWe performed transcriptome-wide
studies to identify CREB target genes
that promote insulin expression and
secretion. This analysis revealed a num-
ber of FSK-inducible genes that contain
CREB-binding sites and that are downre-
gulated following expression of A-CREB
inhibitor. Among these, we identified
MafA, a beta-cell-restricted factor that
regulates the expression of insulin and a
number of genes associated with beta
cell maturity and insulin exocytosis (Ab-
dulahad et al., 2012; Lee et al., 2014;Mar-
tin et al., 2012; Selmi, 2012; Tu et al.,
2012; Figure 2A; Table S1). In addition,
exposure to FSK also stimulated the
expression of a subset of synaptotagmins(Syt4, Syt5, and Syt7), proteins that function as major calcium
sensors for synaptic vesicles (Iezzi et al., 2004, 2005;
Figure S1E).
Realizing the importance of MafA for insulin expression and
secretion, we addressed the potential role of this transcription
factor in mediating effects of CREB on beta cell function. Expo-
sure of isolated mouse islets to FSK increased the expression of
MafA (Figure S1F), which promotes beta cell maturation. Indeed,
islet MafA expression was reduced by two-thirds in pancreatic
islets from MIP-T2KO mice relative to control animals by
immunohistochemical analysis (Figure 2B). As a result, beta
cell maturity gene expression (Glp1r, Pc, and Pdx1) was also
downregulated in CRTC2mutant islets (Figure S1F). Conversely,
CRTC2 overexpression in INS1 cells increased MafA expression
(Figure 2C).
Figure 2. CRTC2 Stimulates MafA Expres-
sion
(A) RNA-seq analysis of INS1 cells exposed to
FSK. Top genes upregulated 2-fold or better
indicated. Effect of dominant-negative A-CREB
expression shown.
(B) Immunohistochemical assay of MafA staining
in islets from pancreatic sections of control and
MIP-T2KO mice. Right, relative number of MafA-
positive cells in control and MIP-T2KO sections
shown (**p < 0.01; n = 5).
(C) Effect of CRTC2 overexpression on MafA
protein amounts in INS1 cells. Exposure to FSK
indicated.
(D) Chromatin immunoprecipitation (ChIP) assay
of INS1 cells showing amounts of CREB and
CRTC2 recruited to the MafA promoter under
basal conditions and following exposure to FSK
(***p < 0.001; n = 6).
(E) Effect of MafA depletion on insulin secretion
from INS1 cells (*p < 0.05; **p < 0.01; n = 6).
(F) Effect of adenoviral GFP control or MafA
overexpression on insulin secretion from MIP-
T2KO mice islets compared to control (**p < 0.01;
n = 6). Data are shown as mean ± SEM.We evaluated whether MafA is a direct target gene for CREB
and CRTC2. Supporting this notion, the MafA promoter contains
a consensus cAMP response element (CRE) that is constitutively
occupied by CREB in INS1 cells (Figures 2D and S1G). In line
with its cytoplasmic sequestration in unstimulated cells (Screa-
ton et al., 2004), amounts of CRTC2 over the MafA promoter
were low under basal conditions but increased following FSK
treatment, when CRTC2 is translocated to the nucleus. Inhibiting
CREB occupancy, through A-CREB overexpression, downregu-
lated MafA gene in INS1 cells (Figure S1H).
We tested whether MafA activity contributes to cAMP-
dependent increases in insulin secretion. In line with this notion,
RNAi-mediated depletion of MafA decreased insulin content
and secretion from INS1 cells, whereas MafA overexpression
increased them (Figures 2E, S1I, and S1J). Indeed, adenoviral
expression of MafA restored insulin secretion to wild-type
levels in CRTC2 mutant pancreatic islets exposed acutely to
glucose plus exendin (Figure 2F). Taken together, these results
demonstrate that CRTC2 promotes beta cell function in part by
upregulating MafA in response to cAMP.
Although initially compensated by an increase in pancreatic
islet mass, prolonged insulin resistance causes impairment inCell Reports 10, 1149–1157, Fbeta cell function that is thought to reflect
the downregulation of certain beta cell
factors including MafA. Having seen that
CREB andCRTC2 promoteMafA expres-
sion in response to cAMP signals, we
tested effects of insulin resistance on
this pathway in pancreatic islets. By
contrast with the robust upregulation of
MafA and other CREB target genes by
FSK in pancreatic islets from lean mice,
FSK had only modest effects on isletsfrom high-fat diet (HFD) mice (Figures 3A, S2A, and S2B). Simi-
larly, effects of FSK on insulin secretion were attenuated in
HFD islets relative to control (Figure S2C). In principle, the loss
of CREB activity in HFD-fed mice could reflect chronic increases
in a number of nutrients including circulating glucose or free fatty
acids. To test the role of hyperglycemia in this process, we per-
formed high-carbohydrate diet (HCD) feeding studies. Although
it had no effect on body weight, HCD feeding impaired glucose
tolerance and insulin secretion after only 8 weeks (Figures
S2D–S2G). Similar to islets from HFD mice, pancreatic islets
from HCD animals showed only modest increases in insulin
secretion and CREB target gene expression following exposure
to FSK (Figures S2H and S2I).
We wondered whether exposure of cultured pancreatic islets
to high concentrations of glucose mimics effects of hyperglyce-
mia on the CREB pathway. Supporting this idea, prolonged
exposure of either INS1 cells or cultured pancreatic islets to
high glucose (20 mM; 72 hr) inhibited the expression of MafA
and other CREB target genes in cells exposed to FSK (Figures
3B, S3A, and S3B). Exposure to 10-mM glucose was not suffi-
cient for PKIB induction in INS1 cells. Indeed, FSK-dependent in-
creases in insulin secretion were substantially downregulated inebruary 24, 2015 ª2015 The Authors 1151
Figure 3. Disruption of the Beta Cell CREB
Pathway in Chronic Hyperglycemia
(A) Relative induction of CREB target genes
by FSK in cultured pancreatic islets from normal
chow (NC)- or high-fat diet (HFD)-fed mice. mRNA
amounts for NR4A2 and MafA shown (**p < 0.01;
n = 6).
(B) Effect of prolonged exposure to high glucose
on FSK-induced increases in MafA protein
amounts.
(C) Effect of chronic high-glucose and adenoviral
MafA expression on insulin secretion from INS1
cells (***p < 0.001; n = 6).
(D) Immunoblots showing effect of prolonged
high-glucose exposure on CREB phosphorylation
(left) and on cellular PKA activity (right) in primary
cultured mouse islets exposed to FSK. Effect
of glucose on phosphorylation of LKB1 at a
consensus PKA site (Ser431) also shown.
(E) RNA-seq analysis of INS1 cells showing effect
of prolonged exposure to high glucose on down-
regulation of cAMP-inducible genes. Effect of FSK
shown.
(F) Effect of HFD feeding on PKIB mRNA (left)
and protein expression (right) in mouse islets
(**p < 0.01; n = 4).
(G) Effect of chronic high-glucose treatment on
nuclear shuttling of PKA catalytic subunit in INS1
cells exposed to FSK. Cytoplasmic (top) and nu-
clear (bottom) fractions shown. Data are shown as
mean ± SEM.INS1 cells exposed to high glucose and FSK (Figure 3C). The
impairment in insulin secretion under chronic high-glucose con-
ditions was partially rescued by MafA overexpression in both
INS1 cells and primary islets (Figures 3C and S3C).
We addressed the mechanism by which high glucose expo-
sure attenuates CREB activity. Although total amounts of
CREB were unchanged, high-glucose treatment disrupted the
FSK-induced phosphorylation of CREB in both INS1 cells and
pancreatic islets (Figures 3D and S3D). Moreover, phospho-
CREB amounts were also downregulated in cultured islets
from HFD and HCD mice (Figures S3E and S3F). Arguing
against an effect on adenyl cyclase or phosphodiesterase activ-
ities, exposure to FSK increased intracellular cAMP concentra-
tions comparably in control and high-glucose-treated INS1 cells
(Figure S3G). Rather, cellular PKA activity was substantially
reduced in islets chronically exposed to glucose, as visualized
in immunoblot assays with phospho-PKA substrate antiserum
(Figure 3D). Consistent with its effects on CREB phosphoryla-
tion, prolonged exposure of INS1 cells to high glucose largely
inhibited the induction of cAMP-responsive genes (Figure 3E;
Table S2).1152 Cell Reports 10, 1149–1157, February 24, 2015 ª2015 The AuthorsHaving seen that chronic glucose
exposure disrupts PKA activity without
affecting cAMP accumulation, we
considered the involvement of a protein
kinase A inhibitor (PKI) in this process.
Consisting of three closely related poly-
peptides (PKIA, PKIB, and PKIG), thePKIs have been shown to bind with high specificity and affinity
to PKA; they also contain a potent nuclear export signal that
maintains PKA in the cytoplasm (Taylor et al., 2005; Fantozzi
et al., 1994; Wen et al., 1994, 1995). PKIB was selectively upre-
gulated in INS1 cells and cultured pancreatic islets following
prolonged exposure to high glucose (Figures S4A and S4B).
Indeed, PKIB mRNA and protein amounts were also increased
in pancreatic islets, but not other metabolic tissues, from
HFD- and HCD-fed mice relative to controls (Figures 3F, S4C,
and S4D).
In immunohistochemical studies, we detected PKIB in beta
cells of the pancreatic islets, but not in surrounding glucagon-
producing alpha cells or in acinar cells of the exocrine pancreas
(Figure S4E). Similar to its effects in mouse islets, chronic
glucose exposure also promoted PKIB expression in human is-
lets, thereby attenuating CREB phosphorylation and target
gene expression (Figures S4F–S4J).
Based on its proposed role in nuclear export, we reasoned that
PKIBmay reduce CREBphosphorylation by blocking the nuclear
accumulation of PKA. Supporting this idea, exposure to FSK
promoted an increase in nuclear amounts of PKA catalytic
Figure 4. PKIB Disrupts Beta Cell Function
(A) Immunoblots showing effect of dsAAV-MIP-
PKIB expression on PKA activity using phospho-
PKA substrate antibody (left) or phospho-CREB
and phosphor-LKB antiserum (right) in MIN6 cells
(n = 4).
(B) Immunohistochemical analysis of GFP
expression from AAV-encoded EGFP virus in
testis, liver, and pancreas 10 days after injection
(n = 3).
(C and D) Body weight (C) as well as circulating ad
libitum glucose concentrations in mice infected
with PKIB or control EGFP (D; **p < 0.01; ***p <
0.01; n = 5)
(E and F) Circulating glucose (OGTT) and insulin
concentrations in mice following oral glucose
administration (F; **p < 0.01; ***p < 0.01; n = 5).
Data are shown as mean ± SEM.subunit in INS1 cells maintained under low-glucose conditions,
but not in cells maintained on high glucose (Figure 3G).
Although PKI potently inhibits PKA activity, the importance of
this pathway for insulin secretion is unclear, as increases in
circulating glucose modulate insulin secretion primarily through
calcium signaling. In that event, the PKIB would cause only
modest changes in circulating glucose and insulin concentra-
tions. To evaluate the effects of this inhibitor on glucose homeo-
stasis, we employed a double-stranded AAV8 vector expressing
PKIB under control of the mouse insulin promoter, which targets
transgene expression specifically to beta cells. Overexpression
of AAV8-encoded PKIB in MIN6 insulinoma cells reduced PKA
activity and correspondingly disrupted CREB phosphorylation
in response to FSK treatment (Figure 4A). Following i.p. adminis-
tration, a control AAV-MIP-EGFP virus was expressed in
pancreatic islets, but not other tissues such as liver and testis
(Figure 4B). Ad libitum circulating glucose concentrations
increased progressively over a 6-week period inmice expressing
AAV-encoded PKIB (Figures 4C and 4D). Although their body
weights were identical to controls, PKIB-overexpressing animals
became relatively glucose intolerant and they had lowerCell Reports 10, 1149–1157, Fcirculating concentrations of insulin in
response to OGTT, indicating that PKIB
expression is sufficient to disrupt beta
cell function (Figures 4E and 4F).
We used mice with a knockout of PKIB
to determine whether the upregulation of
this inhibitor in response to HFD feeding
contributes to the deterioration in
pancreatic islet function. Although they
were otherwise unremarkable (Belyamani
et al., 2001), NC-fed PKIB KO mice were
modestly more glucose tolerant relative
to wild-type littermates by OGTT (Fig-
ure S5A). When placed on a HFD, how-
ever, PKIB mutants had lower fasting
blood glucose concentrations and were
substantially more glucose tolerant (Fig-
ures 5A and S5B–S5D). Moreover, circu-lating insulin concentrations rose 3-fold in PKIB knockout mice
following glucose administration, but they remained unchanged
in controls (Figure 5B). Similarly, MafA expression was strongly
reduced in pancreatic sections from control mice following
HFD feeding, but it remained high in PKIB KO mice (Figure 5C).
Taken together, these results demonstrate that the upregulation
of PKIB in insulin resistance disrupts beta cell CREB activity and
insulin secretion.
In the setting of insulin resistance, chronic hyperglycemia is
thought to promote beta cell hypertrophy in part through the in-
duction of the energy-sensing kinase mTOR. Indeed, prolonged
exposure of pancreatic islets to glucose or FSK triggers the
mTORC1-dependent activation of HIF-1a (Van de Velde et al.,
2011) in beta cells, prompting us to evaluate the role of this
pathway in mediating the induction of PKIB. Exposure of INS1
cells to glucose or FSK increased HIF-1a protein amounts after
12–24 hr followed by increases in PKIB protein amounts
(Figure 5D).
Consistent with a requirement for mTOR activity, exposure to
themTORC1 inhibitor rapamycin effectively blocked the upregu-
lation of PKIB in cells exposed to FSK (Figure 5E). Moreover,ebruary 24, 2015 ª2015 The Authors 1153
Figure 5. Knockout of PKIB Improves
Pancreatic Islet Function in Insulin Resis-
tance
(A) OGTT of PKIB knockout and control littermates
maintained on a HFD for 12 weeks (**p < 0.01;
***p < 0.01; n = 6).
(B) Circulating insulin concentrations in control
and PKIB mutant littermates under basal condi-
tions and 10 min following oral glucose adminis-
tration. Right, relative insulin content in isolated
pancreatic islets (*p < 0.05; ***p < 0.01; n = 6).
(C) Immunohistochemical analysis showing MafA
staining in pancreatic sections from HFD-fed
control mice and PKIB/ littermates.
(D) Time course of PKIB mRNA accumulation in
INS1 cells exposed to FSK (n = 4).
(E) Effect of mTORC1 inhibitor rapamycin on PKIB
mRNA amounts in INS1 cells exposed to FSK for
14 hr (n = 4).
(F) Effect of HIF-1a RNAi-mediated knockdown on
PKIB mRNA levels in INS1 cells (n = 4).
(G) ChIP assays showing effect of short- (2 hr)
or long-term (16 hr) exposure to FSK on HIF-1a
occupancy over the PKIB promoter (***p < 0.001;
n = 6).
(H) Feedback regulation of beta cell CREB ac-
tivity in insulin resistance. Glucose- and incretin-
dependent increases in CREB/CRTC2 activity
during feeding promote the expression of IRS2,
which in turn mediates induction of mTORC1
complexes. When hyperglycemia is prolonged,
increases in HIF-1 protein trigger expression of
PKIB, which downregulates the CREB/CRTC2
pathway by binding to and inhibiting PKA. Data are
shown as mean ± SEM.RNAi-mediated depletion of HIF-1a also disrupted PKIB induc-
tion, whereas HIF-1a overexpression potentiated it (Figures 5F,
S5E, and S5F). The effect of HIF on PKIB expression appears
direct; HIF1 protein amounts over consensus binding sites on
the PKIB promoter increased following prolonged, but not
short-term, FSK treatment of INS1 cells by ChIP assay (Fig-
ure 5G). Indeed, selective induction of endogenous HIF1, by
administration of the prolyl hydroxylase inhibitor DMOG, also up-
regulated PKIB expression, demonstrating that HIF is sufficient
for induction of PKIB in beta cells (Figures S5G and S5H).
DISCUSSION
Taken together, our results show how CRTC2 mediates effects
of incretin hormones through upregulation of MafA and other
CREB target genes that promote insulin gene expression and
secretion (Figure 5H). In response to nutrient stress, GLP1 and
glucose promote pancreatic islet function through increases in
mTORC1 activity that culminate in the induction of the HIF
pathway. When insulin resistance is prolonged, HIF1 inhibits1154 Cell Reports 10, 1149–1157, February 24, 2015 ª2015 The AuthorsCREB activity by stimulating the expres-
sion of PKIB and blocking the activation
of PKA (Figure 5H). Although prolonged
exposure to FSK led to induction ofPKIB in cultured islets, chronic treatment of insulin-resistant
mice with GLP-1R agonist improved glucose intolerance in vivo
(Irwin et al., 2009). Incretin signaling accounts for a large fraction
of post-prandial glucose disposal, and the attenuation of this
pathway in type II diabetes is thought to contribute significantly
to the increased glucose excursions that are characteristic of
this disease (Holst et al., 2011). Indeed, a sizable percentage
of type II diabetic patients appear to be unresponsive to GLP1
agonist therapy (Buysschaert et al., 2012; Hall et al., 2013; Pre-
umont et al., 2012), potentially reflecting the upregulation of
PKIs. Although the mechanism is unclear, PKIA also appears
to be upregulated in pancreatic islets from type II diabetic indi-
viduals (Gunton et al., 2005). Reducing the expression of PKIs
in beta cells may provide therapeutic benefit in this setting.EXPERIMENTAL PROCEDURES
Animals
All studies except for HFD and HCD studies were performed using 10- to 12-
week-old male mice in a C57Bl6 background. Animals were adapted to their
environment for 1 week before studies and were housed in colony cages with a
12 hr light/12 hr dark cycle in a temperature-controlled environment. C57BL6
were purchased from Jackson Laboratories. For HFD studies, C57BL6 mice
were fed a HFD for 20 weeks beginning at 8 weeks of age (60% kcal fat;
D12492; Research Diet). Age-matched C57BL6 on normal chow were used
as controls. For HCD studies, 8-week-old male C57BL6 were maintained in
diet with 73% carbohydrate during 10 weeks (AIN-93M; Research Diet).
PKIB mice were purchased from MMRRC (B6.129P2-Pkibtm1Idz/Mmmh).
MIP-CreERT mice were a gift from Dr. Phillipson of the University of Chicago.
The CRTC2flox/flox mice are homozygous for a ‘‘floxed’’ CRTC2 allele, in which
CRTC2 exons 1 and 5 are flanked by loxP target sites for Cre recombinase.
Animal studies were approved by the Institutional Animal Care and Use
Committee (IACUC) at the Salk Institute.
In Vivo Analysis
At 10 weeks of age, CRTC2 flox/flox MIP-Cre/ERT mice (MIP-T2 KO mice)
were fed with tamoxifen (Sigma; T5648) dissolved in corn oil at 100 mg/kg
body weight (once per day for 5 days). Following tamoxifen administration,
the mice were housed for 5–10 days before being used and analyzed for
Cre-recombinase activity. MIP-T2 KO mice fed with corn oil were used
as controls. Following an overnight fast, mice were administered glucose
(1 g/kg) by oral gavage or by i.p., and glucose levels were measured every
30 min over a 3-hr period. Insulin tolerance was tested by i.p. injection of
6-hr fasted mice with 1 U/kg of insulin (Humulin R; Eli Lilly) followed by blood
glucose measurements every 15 min until 1 hr. For insulin dosage, blood was
taken from the tail vein after 10 min of glucose gavage. dsAAV infections were
carried out at a dose of 4 3 1011 genomes (vg) per mouse. Viruses were
administrated i.p. in a total volume of 800 ml of sterile saline solution contain-
ing 5% sorbitol.
Cell Culture
INS-1 insulinoma cells were cultured in RPMI (Corning cellgro) containing 10%
fetal bovine serum (Gemini Bio Products), 100 mg/ml penicillin-streptomycin,
and 1 mM sodium pyruvate (Corning cellgro). MIN6 cells were grown in
DMEM (Corning cellgro) with 10% FBS, 100 mg/ml penicillin- streptomycin,
and 70 mM beta-mercaptoethanol. For chronic glucose experiments, cells
were maintained under low (2.8 mM) or high (20 mM) glucose for 3 days.
Exendin-4 (10 nM), FSK (10 mM), KCl (40 mM), DMOG (1 mM), and rapamycin
(50 nM) were added to cells as indicated.
cAMP Measurement
Cellular cAMP levels were measured using an ELISA kit (Cayman Chemical
Company) according to manufacturer’s instructions.
RNAi
The sequences of the oligonucleotides used for target rat mafA were as
follows: 50-GAGGAUCUGUAVUGGAUGA-30 and 50 UCAUCCAGUACAGAUC
CUC-30. As a negative control, RNA duplexes targeting GFP were used: 50-
GCAAGCUGACCCUGAAGUUC-30 and 50-GAACUUCAGGGUCAGCUUGC-
30. After annealing, 100 pmol of synthetic duplex was transfected using
Lipofectamine 2000 reagent (Invitrogen) per well (6-well plates) and cells
were harvested 48 hr later.
Islets Isolation and Human Islets
Islets isolation was performed as described previously (Shapiro et al., 1996).
Briefly, pancreata from 10- to 12-week-old mice were injected with Liberase
(0.2 mg/ml; Roche Applied Science) and digested at 37C for 15 min. Prepa-
rations were washed with Hank’s buffered salt solution, and the dissociated
islets were purified on Histopaque gradients (Sigma-Aldrich) and cultured in
RPMI with 10% FBS for 3 days before testing. Human islets were supplied
by the Integrated Islets Distribution Program (IIDP; https://iidp.coh.org/).
Donor information is listed in Table S3.
Insulin Secretion
INS-1 cells or primary islets were starved 2 hr in Krebs-Ringer bicarbonate
HEPES buffer (KRBH) containing 0.2% BSA and exposed to 2.8 mM or
20mMglucose with or without FSK (10 mM) or exendin 4 (10 nM) for 1 hr. InsulinCell Rrelease and content were measured using the ultrasensitive insulin ELISA kit
(Mercodia). Results are presented as insulin secretion (ng/ml) per hour normal-
ized to insulin content. Insulin content is normalized to DNA. Insulin dosage
in vivo was assayed using the ultrasensitive mouse insulin ELISA (Crystal
Chem).
Adenoviruses
For adenoviruses construction, cDNAs were subcloned in the pAdTRACK vec-
tor. Rat PKIB cDNA was obtained by PCR using primers 50-CATCTCGAGAT
GAGGACAGATTC (sense) and 50-CATGGTACCTTATTTGTCTTCGTCTAG
(anti-sense), which introduces XhoI and KpnI sites (underlined), respectively.
Complete viral vectors were generated by homologous recombination with
the AdEASY vector as described (Koo et al., 2005). The MafA adenovirus
was a gift from Dr. T.A. Matsuoka. Adenoviruses were then produced in
MGH cells and purified using CsCl gradients. dsAAV-MIP-EGFP was a gift
from Dr. Paul D. Robbins of the University of Pittsburgh. Mouse PKIB cDNA
was obtained by PCR using primers 50-CATACCGGTATGAGGACAGATTCAT
CAGA (sense) and 50-CATGCGGCCGCTCATTTTCCTTCATTTAG (anti-sense),
which introduces AgeI and NotI (underlined), respectively. The dsAAV virus
expressing mouse PKIb was generated by excising EGFP with restriction en-
zymes AgeI and NotI. Recombinant dsAAV vectors were generating according
to the triple transfection protocol using AAV8 serotype.
Real-Time qPCR and RNA-Seq
Total RNAs from cells or primary islets were extracted using Trizol, and
cDNA was generated using the Transcriptor First Strand cDNA Synthesis
kit (Roche Applied Science). cDNAs were quantified on a Lightcycler 480 in-
strument (Roche Applied Science). Gene expression data were presented
relative to the expression of housekeeping gene L32 (rat samples) and
18S (mouse and human islets). Primer sequences are listed in Table S4.
RNA-seq libraries were prepared using the mRNA isolation protocol and
the NEBNext-Ultra kits from New England Biolabs following the manufac-
turer’s protocols. Libraries were quantitated by Qubit (Invitrogen) and run
on a MiSeq instrument with paired-end 75-bp reads using v3 chemistry (Illu-
mina). Data were analyzed by tophat2 and cuffdiff against the mouse mm10
genome build.
Chromatin Immunoprecipitation
INS-1 cells were plated on 15-cm dishes and exposed to FSK as specified.
Chromatin immunoprecipitation with HIF-1a, CREB, P-CREB, and CRTC2
antisera was performed as described (Ravnskjaer et al., 2007). Oligonucleo-
tides used for ChIP analysis are listed in Table S5.
Protein Analysis
Total protein from cultured cells or primary islets was extracted in a Tris-HCl
buffer containing 0.5% NP40, protease, and phosphatase inhibitors. Proteins
were quantified using Bradford reagent and separated using SDS-PAGE. For
cellular fractionation, cells were resuspended in hypotonic lysis buffer (40 mM
TrisHCl [pH 7.4], 10 mM NaCl, 1 mM EDTA with DTT, and protease inhibitors).
Cells were lysed using a dounce homogenizer and centrifuged. Cytosolic
supernatants were collected. Nuclear pellets were washed three times and re-
suspended in nuclear extraction buffer (40mM TrisHCl [pH 7.4], 420mMNaCl,
10% glycerol, and 1 mM EDTA). Samples were sonicated and centrifuged.
Nuclear supernatants were collected.
Histology
After antigen retrieval, 10-mm frozen pancreatic sections were incubated with
the indicated antibodies overnight and with fluorophore-conjugated second-
ary antibody and DAPI for 1 hr. Sections were mounted with PBS 70% glycerol
and analyzed in a Zeiss VivaTome.
Antisera
Antibodies used for immunoblotting, ChIP, and Immunofluorescence are
indicated in alphabetical order: glucagon (G2654; Sigma-Aldrich); HIF-
1 a (10006421; Cayman Chemical); insulin (180067; ZYMED Labora-
tories); MafA (NB400-137; Novus Biologicals); PKAa cat (sc-903; Santa
Cruz Biotechnology); PKIB (NBP1-74255; Novus Biologicals); PKIB (IF)eports 10, 1149–1157, February 24, 2015 ª2015 The Authors 1155
(NBP1-55720; Novus Biologicals); pLKB1 (pSer428) (C67A3; Cell Signaling
Technology); phospho PKA substrates (100G7E; Cell Signaling Technology);
and tubulin (05-829; Millipore). For CREB, pCREB (pSer133), and CRTC2
detection, rabbit polyclonal antibodies were raised against their respective
antigens.
Statistical Analysis
All mice used in experiments were around 10–12 weeks old except mice in
HFD or HCD. Whenever possible, littermates of appropriate genotype were
used as age-matched controls. The number of mice per experiment was
limited by the availability of the required genotype and age. Criteria of exclu-
sion were (1) gender and age, (2) evident signs of disease, and (3) spontaneous
natural death during the experiment. Sample size (number of mice, islets, and
cells) is within the range of published literature. All results are presented as
means ± SEM. Statistical analysis was performed with unpaired Student’s
t test. Differences were considered statistically significant at p < 0.05 (*p <
0.05; **p < 0.01; and ***p < 0.001).
ACCESSION NUMBERS
The NCBI GEO accession number for RNA-seq studies is GSE60158.
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